These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9384709)

  • 1. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
    Bohlen H; Thielemanns K; Tesch H; Engert A; Wolf HJ; van Camp B; Urbain J; Diehl V
    Cytokines Mol Ther; 1996 Dec; 2(4):231-8. PubMed ID: 9384709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
    Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
    J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
    Weiner GJ; Hillstrom JR
    J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma.
    Demanet C; Brissinck J; Leo O; Moser M; Thielemans K
    Cancer Res; 1994 Jun; 54(11):2973-8. PubMed ID: 8187084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3 x anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model.
    De Jonge J; Heirman C; de Veerman M; Van Meirvenne S; Moser M; Leo O; Thielemans K
    J Immunol; 1998 Aug; 161(3):1454-61. PubMed ID: 9686611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
    Kwak LW; Campbell M; Levy R
    Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of CD40L to a self-tumor antigen enhances the antitumor immune responses of dendritic cell-based treatment.
    Chen HW; Huang HI; Lee YP; Chen LL; Liu HK; Cheng ML; Tsai JP; Tao MH; Ting CC
    Cancer Immunol Immunother; 2002 Aug; 51(6):341-8. PubMed ID: 12111122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy.
    Weiner GJ; Kostelny SA; Hillstrom JR; Cole MS; Link BK; Wang SL; Tso JY
    J Immunol; 1994 Mar; 152(5):2385-92. PubMed ID: 8133049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.
    Flamand V; Sornasse T; Thielemans K; Demanet C; Bakkus M; Bazin H; Tielemans F; Leo O; Urbain J; Moser M
    Eur J Immunol; 1994 Mar; 24(3):605-10. PubMed ID: 8125131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with bispecific antibodies.
    Thielemans KM
    Verh K Acad Geneeskd Belg; 1995; 57(3):229-47; discussion 247-8. PubMed ID: 7483816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trioma-based vaccination against B-cell lymphoma confers long-lasting tumor immunity.
    Mocikat R; Selmayr M; Thierfelder S; Lindhofer H
    Cancer Res; 1997 Jun; 57(12):2346-9. PubMed ID: 9192805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.
    Kwak LW; Campbell MJ; Czerwinski DK; Hart S; Miller RA; Levy R
    N Engl J Med; 1992 Oct; 327(17):1209-15. PubMed ID: 1406793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection.
    Syrengelas AD; Levy R
    J Immunol; 1999 Apr; 162(8):4790-5. PubMed ID: 10202021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
    Kaminski MS; Kitamura K; Maloney DG; Levy R
    J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific antibody therapy of two murine B-cell lymphomas.
    Demanet C; Brissinck J; Moser M; Leo O; Thielemans K
    Int J Cancer Suppl; 1992; 7():67-8. PubMed ID: 1428409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies.
    Cesco-Gaspere M; Benvenuti F; Burrone OR
    Cancer Immunol Immunother; 2005 Apr; 54(4):351-8. PubMed ID: 15692846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.
    Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R
    J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
    Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.